421 related articles for article (PubMed ID: 18504215)
1. [Therapeutic effect of recombinant human brain natriuretic peptide for treatment of decompensated heart failure: comparison with nitroglycerin].
Xie CL; Meng SR; Wang W; Chen SM; Li P; Feng XG
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):839-42. PubMed ID: 18504215
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of the effects of intravenous recombinant human brain natriuretic peptide and nitroglycerin in patients with decompensated acute heart failure: a multicenter, randomized, open-label, parallel-design study].
Recombinant Human Brain Natriuretic Peptide Study Group
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Mar; 34(3):222-6. PubMed ID: 16630454
[TBL] [Abstract][Full Text] [Related]
3. [Acute hemodynamic effects of intravenous recombinant human brain natriuretic peptide in patients with acute myocardial infarction complicated with heart failure].
Li SQ; Fu XH; Liu J; Gu XS; Zhang J; Fan XN; Jiang YF; Miao Q
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jan; 34(1):23-7. PubMed ID: 16626544
[TBL] [Abstract][Full Text] [Related]
4. [The use of recombinant human B-type natriuretic peptide for the protection of cardiac and renal functions in heart failure patients with acute anterior myocardial infarction in peri-operative period of primary percutaneous coronary intervention].
Zhang J; Fu XH; Fan XN; Jia XW; Gu XS; Li SQ; Jiang YF; Fan WZ; Su JL
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Nov; 22(11):669-73. PubMed ID: 21122202
[TBL] [Abstract][Full Text] [Related]
5. [Recombinant human brain natriuretic peptide on the cardiac hemodynamics and renal function in dogs with heart failure].
Xu XW; Zeng GY; Yang Y; Liu HX
Yao Xue Xue Bao; 2002 Oct; 37(10):758-62. PubMed ID: 12567856
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy and safety of intravenous recombinant human brain natriuretic peptide in patients with decompensated acute heart failure: a multicenter, randomized, open label, controlled study].
; Hu DY
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Apr; 39(4):305-8. PubMed ID: 21624304
[TBL] [Abstract][Full Text] [Related]
7. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
[TBL] [Abstract][Full Text] [Related]
8. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Abraham WT; Adams KF; Fonarow GC; Costanzo MR; Berkowitz RL; LeJemtel TH; Cheng ML; Wynne J; ;
J Am Coll Cardiol; 2005 Jul; 46(1):57-64. PubMed ID: 15992636
[TBL] [Abstract][Full Text] [Related]
9. Effects of intravenous nesiritide on pulmonary vascular hemodynamics in pulmonary hypertension.
Michaels AD; Chatterjee K; De Marco T
J Card Fail; 2005 Aug; 11(6):425-31. PubMed ID: 16105633
[TBL] [Abstract][Full Text] [Related]
10. The effect of B-type brain natriuretic peptide on patients with acute decompensated heart failure coexisting with lung cancer: a randomized controlled clinical trial.
Wang S; Qu X; Qu Y; Yu Y; Feng W
Pharmazie; 2014 Mar; 69(3):212-6. PubMed ID: 24716412
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of recombinant human brain natriuretic peptide and dobutamine on acute decompensated heart failure patients with different blood BNP levels.
Pan HY; Zhu JH; Gu Y; Yu XH; Pan M; Niu HY
BMC Cardiovasc Disord; 2014 Mar; 14():31. PubMed ID: 24593826
[TBL] [Abstract][Full Text] [Related]
12. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
Paterna S; Di Pasquale P; Parrinello G; Fornaciari E; Di Gaudio F; Fasullo S; Giammanco M; Sarullo FM; Licata G
J Am Coll Cardiol; 2005 Jun; 45(12):1997-2003. PubMed ID: 15963399
[TBL] [Abstract][Full Text] [Related]
13. Effect of intravenous nitroglycerin on hemodynamics in infants and children with congestive heart failure.
Zeng H; Sun L; Li W; Du J
Chin Med J (Engl); 2000 Apr; 113(4):328-31. PubMed ID: 11775229
[TBL] [Abstract][Full Text] [Related]
14. [Effects of angiotensin converting enzyme inhibitor with different doses on plasma brain natriuretic peptide and norepinephrine in patients with chronic heart failure].
Song HM; Zhang J; Deng B; Luo M
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(25):1737-40. PubMed ID: 16253158
[TBL] [Abstract][Full Text] [Related]
15. [Effects of recombinant human brain natriuretic peptide and milrinone on cardiac hemodynamics and renal function in anesthetized dog].
Xu XW; Yang W; Zhao ZY; Liu HX; Zeng GY
Yao Xue Xue Bao; 2002 Jul; 37(7):506-9. PubMed ID: 12914318
[TBL] [Abstract][Full Text] [Related]
16. [Infusion therapy at outpatient clinic in chronic end-stage heart failure].
Nishi K; Sato Y; Miyamoto T; Taniguchi R; Matsuoka T; Kuwabara Y; Isoda K; Yamane K; Hatakenaka T; Fujinaga K; Fujiwara H; Takatsu Y
J Cardiol; 2007 May; 49(5):251-8. PubMed ID: 17552290
[TBL] [Abstract][Full Text] [Related]
17. Treatment of severe decompensated heart failure with high-dose intravenous nitroglycerin: a feasibility and outcome analysis.
Levy P; Compton S; Welch R; Delgado G; Jennett A; Penugonda N; Dunne R; Zalenski R
Ann Emerg Med; 2007 Aug; 50(2):144-52. PubMed ID: 17509731
[TBL] [Abstract][Full Text] [Related]
18. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study.
Burger AJ; Horton DP; LeJemtel T; Ghali JK; Torre G; Dennish G; Koren M; Dinerman J; Silver M; Cheng ML; Elkayam U;
Am Heart J; 2002 Dec; 144(6):1102-8. PubMed ID: 12486437
[TBL] [Abstract][Full Text] [Related]
19. Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow.
Ezekowitz JA; Hernandez AF; O'Connor CM; Starling RC; Proulx G; Weiss MH; Bakal JA; Califf RM; McMurray JJ; Armstrong PW
J Am Coll Cardiol; 2012 Apr; 59(16):1441-8. PubMed ID: 22497823
[TBL] [Abstract][Full Text] [Related]
20. Do medications affect vital signs in the prehospital treatment of acute decompensated heart failure?
Sporer KA; Tabas JA; Tam RK; Sellers KL; Rosenson J; Barton CW; Pletcher MJ
Prehosp Emerg Care; 2006; 10(1):41-5. PubMed ID: 16418090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
